HOME >> BIOLOGY >> NEWS
Understanding IGF-1: Jefferson researcher sees drug potential in targeting enzyme

Pharmaceutical companies around the world still come knocking on Renato Baserga, M.D.,'s door.

And for good reason.

He has labored for years over trying to understand and detail the behavior of insulin-like growth factor-1 (IGF-1) receptor, a protein which plays an important role in tumor growth. Several years ago he and his co-workers discovered that normal cells lacking the IGF-1 receptor gene could not be made to turn cancerous. He found that when they "knocked out" IGF-1 receptors in cancer cells, the cells self-destructed, meaning the IGF-1 receptor was somehow necessary for tumor cell growth. Companies are interested in targeting the IGF-1 receptor with the idea of killing cancer cells, he says.

According to Dr. Baserga, who is professor of microbiology and immunology at Jefferson Medical College of Thomas Jefferson University in Philadelphia and acting director of Jefferson's Kimmel Cancer Center, in the past few years, scientists have learned that the IGF-1 receptor is also a key growth factor that regulates cell and body size. Deleting the genes for the IGF-1 receptor and its docking protein IRS-1 result in mouse and fly embryos that are only 50 percent of normal size.

"This tells you in essence that the IGF-1 receptor and its docking protein control 50 percent of body size in a non-redundant way," he says. "This was an important finding because it established the role of IGF-1 receptor and IRS-1 in controlling body size."

Reporting August 19, 2005 in the Journal of Biological Chemistry, Dr. Baserga and his co-workers provide one possible molecular explanation for how this occurs.

They found that when IRS-1 is activated with the IGF-1 receptor, -catenin, a protein important in colon and breast cancer is turned on. "We're the first ones to discover that IRS-1 goes to the cell nucleus, where it binds a protein, -catenin, in the nucleus that regulates RNA polymerase 1, the enzyme that controls cell size," he ex
'"/>


20-Sep-2005


Page: 1 2

Related biology news :

1. Understanding why C. difficile causes disease -- its hungry
2. Understanding the global carbon budget -- Woods Hole Research Center expert provides insights
3. Understanding occupational safety and health issues of nanotechnology
4. Understanding the Arctic -- NSF-funded expeditions cover new ground in climate science
5. Understanding climate change: Public forum in Philadelphia next week
6. Understanding food nutrition labels challenging for many people
7. Understanding of cell protection mechanism points to therapies to prevent heart attacks and strokes
8. Understanding the life of C. elegans
9. Drawing a crowd: Understanding the signals that bring inflammatory cells into the lung
10. Jane Lubchenco receives the 2005 AAAS Public Understanding of Science and Technology Award
11. Understanding the oceans microbes is key to the Earths future

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/5/2020)... ... March 05, 2020 , ... In September 2016, stem cell ... Test™ is the first, and still only, available technology that provides the cell-specific ... provide information about the number and quality of therapeutic tissue stem cells are ...
(Date:3/4/2020)... ... March 04, 2020 , ... ... cell banks and hMSC bioprocess systems, announces today a significant milestone in the ... cellular starting materials. The patient has been treated by RoosterBio’s pharmaceutical customer with ...
(Date:3/2/2020)... ... 2020 , ... Philadelphia IP law firm Panitch Schwarze Belisario & Nadel LLP ... as a Partner, and Stephany G. Small, Ph.D., has joined the firm as a ... a partner in the firm’s biotechnology and life science practice group. He has significant ...
Breaking Biology News(10 mins):
(Date:3/13/2020)... (PRWEB) , ... March 12, 2020 , ... ... with the APC Microbiome Ireland SFI Research Center (APC), a pioneer in the ... the body and play a significant role in human health, based at University ...
(Date:3/10/2020)... ... 2020 , ... Lifecycle Biotechnologies announced today that is has acquired ... used as a biopharmaceutical and biotechnology production and development campus. Lifecycle is currently updating ... its production and development hub. The company expects to relocate from Fort Worth, Texas ...
(Date:3/3/2020)... ... , ... Ideal Implant Incorporated Founder and CEO, Robert S ... IMCAS Innovation Shark Tank 2020 in Paris, France in January. The international conference ... industries that promise to revolutionize medical practices in their fields. , “After ...
(Date:2/21/2020)... (PRWEB) , ... February 20, 2020 , ... In a ... join guest speakers from Synteract including Lisa Dilworth, BS, MS, Vice President ... about these challenges, with feasible strategies and solutions to support patients, sites and sponsors. ...
Breaking Biology Technology:
Cached News: